Recent Comments

Comment RSS

Search results for 'Acyclovir'


Phase I clinical trial results for Fentanyl Lauriad announced by BioAlliance Pharma BioAlliance Pharma SA (Euronext Paris – BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced the approval from the French Drug Agency (AFSSaPS) to enter first Phase I clinical trial for Fentanyl Lauriad®. http://www.news-medical.net/news/20091012/Phase-I-clinical-trial-results-for-Fentanyl-Lauriad-announced-by-BioAlliance-Pharma.aspx
FDA approves Sirion's Zirgan for treating acute herpetic keratitis Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that the US Food and Drug Administration (FDA) has approved its New Drug Application for Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% as a treatment for acute herpetic keratitis (dendritic ulcers). The FDA granted orphan drug designation to Zirgan for this indication in April 2007. http://www.news-medical.net/news/20090917/FDA-approves-Sirions-Zirgan-for-treating-acute-herpetic-keratitis.aspx
Clinical trial data of Lipsovir presented at ICAAC Medivir presented Lipsovir (ME-609) at a poster session on 14th September at the ongoing ICAAC (Interscience Conference on Antimicrobial Agents and Chemotherapy) meeting. http://www.news-medical.net/news/20090916/Clinical-trial-data-of-Lipsovir-presented-at-ICAAC.aspx
BioAlliance Pharma's LIP phase III pivotal study provides positive preliminary results BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, is pleased today to announce positive preliminary results in its LIP phase III pivotal study (Lauriad® Immunocompetent Patients Study ). This multicenter randomized, double-blind, placebo controlled study compared the efficacy and safety of a single dose acyclovir Lauriad® 50mg Mucoadhesive Buccal Tablet (MBT) versus matching placebo in patients suffering from recurrent oro-facial herpes. http://www.news-medical.net/news/20090827/BioAlliance-Pharmas-LIP-phase-III-pivotal-study-provides-positive-preliminary-results.aspx
Nanoviricides anti-herpes drug candidate reduces viral load by 99.99% NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), has announced that the herpes simplex viral load was reduced by 99.99% or 10,000 fold in in-vitro studies by nanoviricides™ drug candidates. http://www.news-medical.net/news/20090810/Nanoviricides-anti-herpes-drug-candidate-reduces-viral-load-by-999925.aspx
New research helps explain why treated genital herpes sores boost risk of HIV infection New research helps explain why infection with herpes simplex virus-2 (HSV-2), which causes genital herpes, increases the risk for HIV infection even after successful treatment heals the genital skin sores and breaks that often result from HSV-2. http://www.news-medical.net/news/20090803/New-research-helps-explain-why-treated-genital-herpes-sores-boost-risk-of-HIV-infection.aspx
US FDA approves Lipsovir for cold sores The US Food and Drug Administration (FDA) has now approved Lipsovir, i.e. granted Medivir's New Drug Application (NDA) for the use of acyclovir and hydrocortisone for early treatment of recurrent cold sores to decreases the risk of cold sores, and to shorten the healing time for those cold sores which are not prevented. http://www.news-medical.net/news/20090803/US-FDA-approves-Lipsovir-for-cold-sores.aspx
Herpes drug Acyclovir does not reduce risk of HIV transmission, does slow HIV progression, study says The drug acyclovir, which suppresses herpes simplex virus-2, does not reduce the risk of HIV transmission when taken by HIV-positive people who also have herpes, according to a study conducted by researchers at the University of Washington, United Press International reports. http://www.news-medical.net/news/2009/05/14/Herpes-drug-Acyclovir-does-not-reduce-risk-of-HIV-transmission-does-slow-HIV-progression-study-says.aspx
Anti-herpes drug acyclovir inhibits HIV replication, but with a price The anti-herpes drug acyclovir can also directly slow down HIV infection by targeting the reverse transcriptase (RT) enzyme, researchers report in this week's JBC. http://www.news-medical.net/news/2008/11/07/42549.aspx
Herpes drug Acyclovir could help control HIV Acyclovir -- a low-cost, generic drug used to treat herpes -- also might help control HIV in people living with both viruses, according to a study published Wednesday in the journal ell Host and Microbe, Reuters reports. http://www.news-medical.net/news/2008/09/15/41446.aspx
Herpes virus changes anti-herpes drug acyclovir to form that hinders AIDS virus The drug acyclovir has long been used to suppress outbreaks of oral and genital herpes. Herpes viruses change acyclovir to a form that prevents them from reproducing. http://www.news-medical.net/news/2008/09/10/41368.aspx
New understanding of how herpes simplex virus 1 hides during inactive phase Now that Duke University Medical Center scientists have figured out how the virus that causes cold sores hides out, they may have a way to wake it up and kill it. http://www.news-medical.net/news/2008/07/03/39717.aspx
New therapeutic options for newly diagnosed multiple myeloma patients Mayo Clinic researchers presented results of a phase II trial of myeloma induction therapy -- a first step therapy designed to reduce cancer cells numbers -- with cyclophosphamide, bortezomib, and dexamethasone (Cybor-D) showing an improved response over the traditional lenalidomide-dexamethasone (L-Dex) therapy. http://www.news-medical.net/news/2007/12/10/33390.aspx
Immtech and BioAlliance sign agreement on Pafuramidine for African sleeping sickness Immtech Pharmaceuticals has announced that the Company has granted an exclusive license to BioAlliance Pharma SA to commercialize Immtech's oral drug, pafuramidine maleate (pafuramidine), in Europe for the treatment of pneumocystis pneumonia (PCP) in AIDS patients and for the treatment of Human African trypanosomiasis, also known as African sleeping sickness. http://www.news-medical.net/news/2007/12/05/33209.aspx
New treatment a cure for Bell's Palsy Scottish experts have discovered that Bell's Palsy, a syndrome which causes the muscles on one side of the face to become paralysed, can now be cured by a new steroid treatment. http://www.news-medical.net/news/2007/10/19/31444.aspx
Long-term herpes treatment may reduce HIV infectivity Long-term anti-herpes treatment of women infected with both HIV and HSV2, the virus that causes genital herpes, may reduce the proportion of women with detectable HIV virus in their genital secretions according to the results of a trial in Tanzania presented the International AIDS Society Conference in Sydney. http://www.news-medical.net/news/2007/07/26/28101.aspx
Treatment with intravenous and oral antiviral medications may help relieve nerve pain related to shingles A small trial suggests that treatment with intravenous and oral antiviral medications may reduce the nerve pain that occurs following shingles, according to a study posted online today that will appear in the July 2006 print issue of Archives of Neurology. http://www.news-medical.net/news/2006/05/09/17836.aspx
Acyclovir use uncertain in children with chickenpox There seems to be little value in using acyclovir to treat children with chickenpox who are otherwise healthy. http://www.news-medical.net/news/2005/10/18/13854.aspx
Chickenpox (Varicella) vaccine has saved the U.S. hundreds of millions of dollars since its introduction A new University of Michigan study has found that the Chickenpox (Varicella) vaccine has saved the U.S. hundreds of millions of dollars since its introduction in 1995 by preventing the kinds of severe cases that used to send children, teens and adults to the hospital. http://www.news-medical.net/news/2004/09/07/4553.aspx
Third Annual Encephalitis Conference International organizers are proud to announce the FACES to FACES Encephalitis Conference, to be held in Enfield Connecticut USA on August 6th to August 8th, 2004. http://www.news-medical.net/news/2004/04/26/842.aspx
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.